Clinical Trial

Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC

Recruiting
View on ClinicalTrials.gov →
Summary
This prospective clinical observational study aims to construct a metabolite database specifically for gastric cancer patients using metabolomics technology. It seeks to develop and validate metabolic biomarkers for early diagnosis, prognosis, and prediction of recurrence and metastasis in gastric cancer, thereby a establishing safe, convenient, and highly sensitive method for early screening and prognostic prediction.
Trial Details
NCT Number NCT07076979
Lead Sponsor Shanghai Minimally Invasive Surgery Center
Conditions Gastric Cancer
Enrollment 250 participants
Start Date 2025-06-15
Primary Completion 2028-07-01 (estimated)
Study Completion 2030-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-22